We focus on developing innovative enriched-cannabis products via a precise and reproducible manufactory process. Our goal is to develop a range of effective accurate formulations to serve patients worldwide.
Bazelet’s technology uses its science, diversity, creativity, vast patient knowhow and proprietary manufacturing knowledge to best serve its patients, to further improve production, to form new products and delivery methods and to explore new applications for its products.
Bazelet has filed so far 35 provisional patent applications, 2 of them have been granted (USA) and another 25 are in the PCT stage.
A recent product of Bazelet’s innovative R&D group is a novel terpenes-enriched cannabis formulation directed to enhance the therapeutic effect in an array of medical conditions.
Bazelet intellectual property further covers fields or terpenes-enriched cannabis formulations, extraction methods, cannabis-based veterinary composition, and honey-cannabinoid composition.
As Israel will soon allow the export of medical cannabis, Bazelet invites companies to learn about its terpene technology and enter partnerships to provide the highest quality medical cannabis globally to patients and communities.